NMRA · Neumora Therapeutics, Inc.
$1.61
+0.01 (+0.63%)
At close · Jul 17
Market Cap
$298.31M
Shares
185,284,244
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-15 | 2026-06-10 | |
| 8-K | 2026-05-29 | 2026-05-27 | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-17 | 2026-05-27 | |
| 8-K | 2026-03-30 | — | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-02-11 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-05 | — | |
| 8-K | 2025-11-21 | 2025-11-17 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-27 | — | |
| 8-K | 2025-10-27 | — | |
| 8-K | 2025-08-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-05-30 | 2025-05-28 | |
| 8-K | 2025-05-16 | 2025-05-14 | |
| 8-K | 2025-05-12 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| DEF 14A | 2025-04-29 | 2025-05-28 | |
| 8-K/A | 2025-04-11 | 2025-02-13 | |
| 10-K | 2025-03-03 | 2024-12-31 | |
| 8-K | 2025-03-03 | — | |
| 8-K/A | 2025-02-21 | 2025-02-13 | |
| 8-K | 2025-02-13 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2025-01-02 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-06-14 | 2024-06-13 | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| 8-K | 2024-05-07 | — | |
| DEF 14A | 2024-04-25 | 2024-06-13 | |
| 8-K | 2024-04-15 | — | |
| 10-K | 2024-03-07 | 2023-12-31 | |
| 8-K | 2024-03-07 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-11-28 | 2023-11-27 | |
| 8-K | 2023-11-01 | — | |
| 10-Q | 2023-11-01 | 2023-09-30 | |
| 8-K | 2023-09-19 | — |
Showing 1–46 of 46 filings